Urolithin A vs Astaxanthin: What's the Difference?

Urolithin A and astaxanthin are both popular in the healthy-aging aisle, yet they solve different problems. Urolithin A renews the mitochondria that power your cells, while astaxanthin is a deep-red marine antioxidant studied mostly for skin, eye and oxidative-stress support. Once you see the mechanism split, choosing between them gets simple.

The short answer

Urolithin A is a gut postbiotic that supports mitophagy — the recycling of worn-out mitochondria — and it has a growing base of human clinical evidence for muscle and cellular energy. Astaxanthin is a carotenoid pigment (the compound that gives salmon, shrimp and flamingos their color), sourced largely from the microalga Haematococcus pluvialis, and it is prized as a potent antioxidant studied for skin quality, eye comfort and general oxidative-stress support. If your goal is mitochondrial and muscle-related energy, urolithin A is the more directly relevant compound. If you are drawn to antioxidant, skin and eye support, astaxanthin is the more traditional fit.

How urolithin A works

Urolithin A is not eaten directly. It is created in the gut when microbes break down ellagitannins, large polyphenols concentrated in pomegranates, walnuts and certain berries. Only some people carry a microbiome capable of converting ellagitannins into meaningful amounts of urolithin A, which is precisely why a measured supplemental dose has become the dependable route.

Its defining action is mitophagy. Mitochondria turn food and oxygen into usable energy, and they accumulate damage as they work. Mitophagy is the quality-control process that tags and clears the worn units so the cell can maintain a healthier mitochondrial population. When that recycling slows with age, damaged mitochondria accumulate and cellular energy output tends to decline. By supporting mitophagy, urolithin A is framed as a mitochondrial-renewal compound rather than a general antioxidant — a genuinely different mechanism from a free-radical scavenger.

The human evidence for urolithin A

Urolithin A is notable for reaching human clinical trials. We separate the evidence tiers on purpose.

• Human — first-in-human safety. Andreux et al. (2019, Nature Metabolism) found urolithin A safe and well tolerated up to 1,000 mg per day, with a measurable mitochondrial gene-expression signature.
• Human — muscle endurance. Liu, D'Amico and colleagues (2022, JAMA Network Open) reported that about four months of use in older adults supported muscle endurance, measured as contractions before fatigue.
• Human — strength and performance. Singh et al. (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg daily in middle-aged adults over four months and reported benefits for muscle strength and exercise performance.
• Human — immune-cell mitochondria. A 2025 Nature Aging randomized trial (about 28 days) found urolithin A supported the mitochondrial health of immune cells in midlife adults, tied to the concept of “inflammaging.”
• Human — athletes. An 8-week randomized trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 2024) examined endurance and recovery markers, with a 2025 distance-runner trial adding further data.

For honesty about limits: a 2024 systematic review in Ageing Research Reviews concluded the human evidence is still emerging, from relatively short trials with modest sample sizes. The foundational work by Ryu et al. (2016, Nature Medicine) — mitophagy, lifespan in C. elegans and muscle function in rodents — is preclinical and should not be read as proof of the same outcomes in people.

How astaxanthin works

Astaxanthin is a xanthophyll carotenoid with an unusual molecular structure that lets it sit across cell membranes and neutralize reactive oxygen species on both the inner and outer surfaces. This is why it is often described as an especially powerful lipid-soluble antioxidant. Because it also carries a red pigment, it accumulates in tissues and gives seafood like salmon and shrimp their color.

In humans, astaxanthin's most consistent research is in skin health — systematic reviews of clinical studies have examined markers such as skin moisture, elasticity and the appearance of fine lines — along with eye comfort (including eye fatigue in screen users) and general oxidative-stress and exercise-recovery support. Its skin data are among the more developed human antioxidant literatures, though study sizes and designs vary, and reviewers generally call for larger, longer trials before drawing firm conclusions. Its brain, heart and other longevity applications remain earlier and more preclinical.

Importantly, astaxanthin is an antioxidant that works downstream, quenching free radicals after they form. It does not act on mitophagy and does not renew mitochondria the way urolithin A is studied to do. Eye and skin topics are also condition-adjacent for some people — astaxanthin is not a treatment for any eye or skin disease, and persistent concerns belong with a doctor or dermatologist.

Head-to-head: the core difference

The cleanest split is renewal versus defense.

Urolithin A = mitochondrial renewal

Urolithin A works upstream, supporting the clearance and replacement of damaged mitochondria before they drag down cellular energy. Its strongest human signals are in muscle endurance, strength and cellular energy, as detailed in the clinical studies above. It is not primarily an antioxidant, and that is the point of difference.

Astaxanthin = antioxidant defense

Astaxanthin works downstream as a membrane-spanning antioxidant, with its best human data in skin quality, eye comfort and oxidative-stress support. It does not have a mitophagy mechanism and does not carry urolithin A's muscle-endurance human trial base. Think of it as a shield against oxidative damage rather than a renewal system for your cellular power plants.

Are they complementary?

Yes, arguably more so than most pairings on these comparison pages, because renewal and antioxidant defense are genuinely different jobs. Someone focused on cellular energy and muscle resilience might center their routine on urolithin A for mitophagy support, while adding astaxanthin for its antioxidant, skin and eye angle. Since they act on separate pathways, using both layers two distinct kinds of support rather than duplicating one. That said, there is no well-established human trial on the specific combination, so any pairing rests on their individual mechanisms, not proven synergy. Both are structure/function supplements, not treatments — if you manage a diagnosed skin, eye or other condition, or take medication, talk with your healthcare provider before adding either.

How to choose by goal

Choose urolithin A if…

Your priorities are mitochondrial health, cellular energy, or maintaining muscle strength and endurance with age, and you value a longevity compound backed by human clinical data. It also fits if you eat few ellagitannin-rich foods and suspect your gut converts them poorly. Our complete urolithin A guide, our best urolithin A gummies roundup and our page on urolithin A for muscle go further.

Choose astaxanthin if…

You want antioxidant coverage with a skin- and eye-support emphasis, and you are comfortable with a compound whose strongest human data sit in those cosmetic and comfort areas rather than in muscle or cellular-energy outcomes. Look for a product sourced from natural Haematococcus pluvialis algae.

Dosing and format notes

Urolithin A's clinically studied range is 500–1,000 mg per day, with 1,000 mg at the top; SOMA HEALTH delivers 1,000 mg in a four-gummy daily serving. Astaxanthin is dosed in far smaller amounts — typically single-digit milligrams — because it is a pigment-based antioxidant with different potency math; check the current label for a given product. That milligram gap reflects two very different kinds of compounds, not a difference in “strength.” See urolithin A dosage for specifics.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.